AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in bcg-primed non-human primates

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Jeyanathan, Mangalakumari ^a   Shao, Zhongqi ^b   Yu, Xuefeng ^b   Harkness, Robin ^b   Jiang, Rong ^b   Li, Junqiang ^b   Xing, Zhou ^a   Zhu, Tao ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b Tianjin CanSino Biotechnology Inc   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; C REACTIVE PROTEIN; GAMMA INTERFERON; ACYLTRANSFERASE; ANTIGEN 85A, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPETITE; ARTICLE; BACTERIAL LOAD; BCG VACCINATION; BODY TEMPERATURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN ADENOVIRUS 5; IMMUNOGENICITY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RHESUS MONKEY; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT OUTCOME; ADENOVIRIDAE; ANIMAL; BRONCHOSCOPY; IMMUNOLOGY; LUNG; METABOLISM; MONONUCLEAR CELL; MUCOSAL IMMUNITY; PROCEDURES; RESPIRATORY MUCOSA; THORAX RADIOGRAPHY; TUBERCULOSIS, PULMONARY; VACCINATION;

ACYLTRANSFERASES; ADENOVIRIDAE; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; BRONCHOSCOPY; IMMUNITY, MUCOSAL; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LUNG; MACACA MULATTA; MALE; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; RESPIRATORY MUCOSA; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84941959798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135009     Document Type: Article

References (34)

1. WHO. Global tuberculosi report 2014. World Health Organization. 2014. http://apps.who.int/iris/ bitstream/10665/137094/1/9789241564809-eng.pdf?ua=1.
2. Kaufmann S. Tuberculosis vaccines: time to think about the next generation. Semin Immunol. 2013; 25:172-181. doi: 10.1016/j.smim.2013.04.006 PMID: 23706597
3. Xing Z, Jeyanathan M, Smaill F. New approaches to TB vaccination. Chest 2014; 146: 804-812. doi: 10.1378/chest.14-0439 PMID: 25180725
4. Brennan MJ, Thole J. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis 2012; 92 Suppl 1: S6-13. doi: 10.1016/S1472-9792(12)70005-7 PMID: 22441160
5. Jeyanathan M, Heriazon A, Xing Z. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol. 2010; 31: 247-252. doi: 10.1016/j.it.2010.05.002 PMID: 20542470
6. Beverley PC, Sridhar S, Lalvani A, Tchilian EZ. Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol. 2014; 7: 20-26. doi: 10.1038/mi.2013.99 PMID: 24253104
7. Horvath CN, Shaler CR, Jeyanathan M, Zganiacz A, Xing Z. Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol. 2012; 5: 420-431. doi: 10.1038/mi.2012.19 PMID: 22453678
8. Shaler CR, Horvath C, Lai R, Xing Z. Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin Dev Immunol. 2012; 2012: 628293. doi: 10.1155/2012/628293 PMID: 22545059
9. Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal immunol. 2011; 4: 288-293. doi: 10.1038/mi.2011.10 PMID: 21451503
10. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Shea JE, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo- controlled phase 2b trial. Lancet 2013; 381: 1021-1028. PMID: 23391465
11. Abel B, Tameris M, Mansoor N, Gelderbloem S, Hughes J, Abrahams D, et al. The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med. 2010; 181: 1407-1417. doi: 10.1164/rccm.200910-1484OC PMID: 20167847
12. Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige-Don N, Zganiacz A, et al. A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med. 2013; 5: 205ra134. doi: 10.1126/scitranslmed.3006843 PMID: 24089406
13. Satti I, Meyer J, Harris SA, Manjaly Thomas ZR, Griffiths K, Antrobus RD, et al. Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infect Dis. 2014; 14: 939-946. doi: 10.1016/S1473-3099(14)70845-X PMID: 25151225
14. Scanga CA, Flynn JL. Modeling Tuberculosis in Nonhuman Primates. Cold Spring Harbor Perspectives in Medicine 2014; 4: a018564. doi: 10.1101/cshperspect.a018564 PMID: 25213189
15. Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 2005; 23: 2740-2750. PMID: 15780721
16. Reed SG, Coler RN, Dalemans W, Tan EV, DeLa Cruz EC, Basaraba RJ, et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci. USA 2009; 106: 2301-2306. doi: 10.1073/pnas.0712077106 PMID: 19188599
17. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PloS One 2009; 4: e5264. doi: 10.1371/journal.pone. 0005264 PMID: 19367339
18. Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, et al. rBCG induces strong antigen- specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PloS One 2008; 3: e3790. doi: 10.1371/journal.pone.0003790 PMID: 19023426
19. Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S, et al. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge. J Immunol. 2014; 193: 1799-1811. doi: 10.4049/jimmunol.1400676 PMID: 25024382
20. White AD, Sibley L, Dennis MJ, Gooch K, Betts G, Edwards N, et al. Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques. Clin Vaccine Immunol.: 2013; 20: 663-672. doi: 10.1128/CVI.00690-12 PMID: 23446219
21. Dean G, Whelan A, Clifford D, Salguero FJ, Xing Z, Gilbert S, et al. Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines. Vaccine 2014; 32: 1304-1310. doi: 10.1016/j.vaccine.2013.11. 045 PMID: 24269321
22. Zhang J, Xian Q, Guo M, Huang Z, Rao Y, Wang Y, et al. Mycobacterium tuberculosis Erdman infection of rhesus macaques of Chinese origin. Tuberculosis 2014; 94: 634-643. doi: 10.1016/j.tube.2014.08. 005 PMID: 25224753
23. Capuano SV 3rd, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun. 2003; 71: 5831-5844. PMID: 14500505
24. Luciw PA, Oslund KL, Yang XW, Adamson L, Ravindran R, Canfield DR, et al. Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. Am J Physiol Lung Cell Mol Physiol. 2011; 301: L731-738. doi: 10.1152/ ajplung.00120.2011 PMID: 21873450
25. Lin PL, Pawar S, Myers A, Pegu A, Fuhrman C, Reinhart TA, et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006; 74: 3790-3803. PMID: 16790751
26. Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update. Transl Resp Med 2014; 2: 3.
27. Low N, Kraemer S, Schneider M, Restrepo AM. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis. Vaccine 2008; 26: 383-398. PMID: 18082295
28. Rubin BA, Rorke LB. Adenovirus vaciines. In: Plotkin SA, Mortimer EA, editors. Vaccines. Philadelphia: Saunders. 1998. pp. 492-512.
29. Johnson MJ, Petrovas C, Yamamoto T, Lindsay RW, Lore K, Gall JG, et al. Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity. J Immunol. 2012; 188: 6109-6118. doi: 10.4049/jimmunol.1103717 PMID: 22586038
30. Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, Bafica A, et al. Intranasal Poly- IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest. 2010; 120: 1674-1682. doi: 10.1172/ JCI40817 PMID: 20389020
31. Jeyanathan M, Damjanovic D, Shaler CR, Lai R, Wortzman M, Yin C, et al. Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. Mucosal Immunol. 2013; 6: 612-625. doi: 10.1038/mi.2012. 103 PMID: 23131783
32. Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ, et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res. 2005; 25: 694-701. PMID: 16318583
33. Smith DG. Genetic characterization of Indian-origin and Chinese-origin rhesus macaques (Macaca mulatta). Comparative Med. 2005; 55: 227-230.
34. Langermans JA, Andersen P, van Soolingen D, Vervenne RA, Frost PA, van der Laan T, et al. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci USA. 2001; 98: 11497-11502. PMID: 11562492